Neogenix Oncology, Inc. Will Present Data on a New Stool Biomarker Test for the Detection of Colorectal Cancer at American Society of Clinical Oncology's 2011 Gastrointestinal Cancers Symposium
1/19/2011 10:39:33 AM
(BUSINESS WIRE)--Neogenix Oncology announced today that it will present data on the development of a new stool biomarker ELISA that could lead to earlier detection of colorectal cancer. Data will be presented at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.
comments powered by